Results 71 to 80 of about 17,587 (206)

Reproductive Health Outcomes Associated With Domestic Violence Among Iranian Women During the COVID‐19 Pandemic: A Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background and Aims Domestic violence (DV) is a major public health concern that negatively affects women's reproductive health. The COVID‐19 pandemic and related lockdowns may have exacerbated DV and its consequences. This study aimed to assess reproductive health outcomes associated with DV among married women in Iran during the COVID‐19 ...
Maryam Gharacheh   +5 more
wiley   +1 more source

Very low sensitivity of wet mount microscopy compared to PCR against culture in the diagnosis of vaginal trichomoniasis in Uganda: a cross sectional study

open access: yesBMC Research Notes, 2017
BackgroundTrichomonas vaginalis (TV) causes the Trichomoniasis Syndrome composed of vaginitis in women, urethritis in men and tube infection in both sexes.
Sheila Nabweyambo   +7 more
semanticscholar   +1 more source

The Role of Enterococcus faecium in the Synergistic Clearance of High‐Risk HPV: A Clinical Study on Cervicovaginal Microbiota Regulation

open access: yesCancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background Persistent infection with high‐risk human papillomavirus (HR‐HPV) is defined as the principal cause of cervical cancer. Given the important role of cervicovaginal microbiota in HPV acquisition and disease progression, this study aims to evaluate the clinical efficacy of the probiotic Enterococcus faecium (E.
Jun Yang   +6 more
wiley   +1 more source

Effects of vaginal microbiota transfer on social–emotional and neurodevelopment in cesarean‐born infants: 12‐month follow‐up of a pilot randomized clinical trial

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 6, Page 1064-1074, June 2026.
In a pilot randomized clinical trial of cesarean‐born infants, vaginal microbiota transfer improved social–emotional development at 12 months, reducing social–emotional risk and improving key subdomains, while early neurodevelopmental benefits observed at 6 months were not sustained at 12 months. Abstract Introduction To evaluate the effects of vaginal
Chuhui Zhou   +9 more
wiley   +1 more source

Challenges and Persistent Questions in Treatment of Trichomoniasis

open access: yesCurrent Topics in Medicinal Chemistry, 2016
Trichomoniasis is a sexually transmitted disease (STD) caused by infection with the protozoan parasite Trichomonas vaginalis. It is considered the most prevalent non-viral sexually transmitted disease worldwide.
Patrícia de Brum Vieira   +2 more
semanticscholar   +2 more sources

Metronidazole‐resistant trichomoniasis: beneficial pharmacodynamic relationship with high‐dose oral tinidazole and vaginal paromomycin combination therapy: 3

open access: yesSexually Transmitted Diseases, 2018
Metronidazole-resistant trichomoniasis is an uncommon condition that presents significant therapeutic challenges. Combination therapy with high-dose oral tinidazole and vaginal paromomycin cream has been uniformly successful.
Mira N Henien   +2 more
semanticscholar   +1 more source

Probiotic supplementation during pregnancy for vaginal microbiota improvement and pathogen clearance: A systematic review and meta‐analysis

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 6, Page 999-1016, June 2026.
Probiotic supplementation during pregnancy shows a modest, non‐robust increase in Group B Streptococcus decolonization, with no consistent benefit for bacterial vaginosis or vulvovaginal candidiasis. Probiotics may serve as a non‐antibiotic adjunct, but standardized regimens and ecological diagnostic frameworks are required.
Zimo Liu   +3 more
wiley   +1 more source

Therapy chronic trichomoniasis at patients with associated urogenital chlamydial infection [PDF]

open access: yes, 2014
Present material of problem question therapy chronic trichomoniasis. Study clinical and bacteriological effectiveness basic etiotropic preparation and their combination, used in treatment patients trichomoniasis.
I. M. Kovalishin   +5 more
core   +1 more source

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5163-5173, June 2026.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and sodium–glucose cotransporter 2 (SGLT2) inhibitors are widely used for the treatment of type 2 diabetes, yet their downstream consequences in routine clinical practice remain incompletely characterized.
Yazan Alhamdan   +2 more
wiley   +1 more source

Survey of Obstetrician-gynecologists in the United States About Trichomoniasis, 2016

open access: yesSexually Transmitted Diseases, 2018
Purpose Trichomoniasis is the most prevalent nonviral sexually transmitted infection (STI) in the United States. It can present with vaginitis in women and urethritis in men, but is most often asymptomatic or occurs with minimal symptoms.
Eugene W. Liu   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy